Accessible, high-quality medicine you can trust—delivered with excellence and care since 1966.
Certified by leading global regulatory authorities—including the U.S. FDA, EU EMA, Japan PMDA, Taiwan TFDA, China NMPA, and Brazil ANVISA—our manufacturing sites meet the highest global standards for safety, efficacy, and quality of our products.
We uphold rigorous quality management across every stage of production and cultivate a company‑wide culture where quality is foundational. This commitment ensures our products consistently earn the trust of patients, healthcare providers, and global partners.
Business
Apr 8, 2026
Taipei, Taiwan, 08 April 2026 — Lotus Pharmaceutical Co., Ltd. (Taiwan Stock Exchange: 1795), a global pharmaceutical company headquartered in Taiwan, today announced that Zepzelca® (lurbinectedin), its licensed oncology product, has receiv...
Business
Apr 2, 2026
Taipei, Taiwan, 02 April 2026 — Lotus Pharmaceutical Co., Ltd. (Taiwan Stock Exchange: 1795), a leading global pharmaceutical company, today announced that it has entered into an agreement to acquire Sandoz AG’s Philippines business. Subj...
Business
Feb 24, 2026
Taipei, Taiwan, 24 February 2026 — Lotus Pharmaceutical Co., Ltd. (Taiwan Stock Exchange: 1795), a leading global pharmaceutical company, today announced that it has filed a New Drug Application (“NDA”) under the 505(b)(2) regulator...
